Generic medicines: The dilemma

Columnist-Dr. R K Chadha

Illness can impose a substantial financial burden. For millions of families in our country, a prescription is not simply a list of medicines; it can become a recurring monthly expense. When a doctor writes a prescription, the patient frequently faces a dilemma: should they choose a branded medicine or a cheaper generic alternative? In 2026, digital pharmacy platforms (e-pharmacies) saw a sudden surge in apps offering affordable substitutes for branded generic medicines from reputed pharmacy chains. This article explains common pharmaceutical terms and examines why generic medicines have struggled to gain widespread acceptance in Bharat.

Medicines: Medicines are high-tech, complex formulations of substances that interact with the human body to treat or cure diseases, infections, and other medical conditions. A medicine typically consists of two key components: i) an Active Pharmaceutical Ingredient (API), which is the drug molecule responsible for the therapeutic healing properties, and ii) excipients or Inactive Pharmaceutical Ingredients (IPI). These inactive substances ensure the medicine remains stable, manufacturable, and acceptable to patients, while also facilitating the effective delivery of the API to the body in the form of a tablet, capsule, or injection.

Drug or API: A drug, or Active Pharmaceutical Ingredient (API), is a chemical compound consisting of two or more atoms bound together in a specific structural arrangement called a molecule. Each drug molecule acts as a single functional unit that retains the core chemical and therapeutic properties of the substance. For instance, paracetamol is the API commonly prescribed to treat fever and pain, and its molecular formula is C₈H₉NO₂ (where subscripts denote the number of each atom). While paracetamol is the generic name of the medication, it is sold in pharmacies under various brand names such as Crocin, Dolo, Calpol, Pacimol, and Metacin. Similarly, metformin hydrochloride (C₄H₁₁N₅ · HCl) is a widely used generic API for managing diabetes, available in the market under brand names like Glycomet, Glyciphage, Melmet, Gluformin, Obimet, and Okamet.

Let me explain a molecule with a Lego-block analogy. Imagine atoms of carbon, hydrogen, oxygen, and nitrogen as Lego blocks of different shapes and colours. Joined in a particular arrangement, they form different models, a car, a house, or any other structure. The completed models represent different molecules depending on their specific arrangements. Similarly, atoms combine in specific ways to form molecules. Just as altering the number or arrangement of Lego blocks changes the final model, altering the atoms or their arrangement changes a drug molecule, thereby changing the medicine’s properties and its applications.

Excipients: These are the Inactive Pharmaceutical Ingredients (IPI) added to a medicine to make it stable, manufacturable, acceptable to patients, and effective in delivering the API to the human body. These ingredients are fillers, binders, coatings, preservatives, or flavouring agents. For example, some of the fillers are starch, lactose, microcrystalline cellulose, or dicalcium phosphate that add bulk to the API, which are generally in milligrams. Binders are starch, gelatin, povidone (PVP), and hydroxypropyl cellulose that hold powder particles together and give the tablet mechanical strength. Disintegrants like sodium starch glycolate and croscarmellose sodium help the tablet break apart in the stomach so that API can dissolve and be absorbed. Coating agents like hydroxypropyl methylcellulose (HPMC), ethylcellulose, and polyvinyl alcohol protect the tablet, mask taste, make swallowing easier, or control drug release, and antioxidants and chelating agents protect the API from degrading or oxidizing in liquid form in injections.

Medicine types: Original (Patented): Developing a new drug molecule (API) involves painstaking, costly, and time-consuming laboratory research, clinical trials, stringent regulatory scrutiny, and complex manufacturing processes. So, an innovator pharmaceutical company patents its new discovery and markets it under a proprietary trade or brand name to recoup the costs. A patent is typically valid for 20 years which gives them exclusive rights to manufacture and sell the product and prohibit other companies to produce its generic version. A few examples of such global and domestic pharmaceutical companies are Pfizer, Novartis, Dr. Reddy’s or Sun Pharma. Once the original drug’s patent and regulatory exclusivity periods expire, the market opens to Generic Medicines that can be manufactured by any pharmaceutical company either under its generic API’s name or by filing an Abbreviated New Drug Application (ANDA) for a new brand name.

Generic and Branded Generic medicines: The API in a drug molecule is typically its generic name, which is non-proprietary with an International Non-proprietary Name (INN). A generic medicine is approved only if it passes a bioequivalence trial. A bioequivalence trial is a specialized clinical study designed to compare how two different versions of a drug behave in the human body. Specifically, it proves whether a generic medicine delivers the same amount of API into the bloodstream at the same rate as the original innovator (patented) drug. If two medicines are bioequivalent, regulators consider them therapeutically interchangeable, meaning they will have the exact same clinical effect and safety profile.

OrangeNews9

If a medicine is sold under its API name, it is called a generic medicine, and if it is sold under a new brand (other than Patented) it is called a branded generic. For example, if the prescribed medicine for fever and pain is sold as “Paracetamol,” it is generic, and if it is sold as Crocin, Dolo, Calpol, Pacimol, Metacin, it is a branded generic. In the same way for diabetes, Metformin hydrochloride is a generic medicine and Glycomet, Glyciphage, Melmet, Gluformin, Obimet, and Okamet are branded generics. In generic drugs, different excipients (binders, flavourings, colours) are permitted to look different in shape or colour to satisfy trademark laws.

The Paradox: Bharat has earned the title as “pharmacy of the world” as one of the world’s largest suppliers of generic medicines, with nearly 40 per cent of generics used in the United States are sourced from India. More than 90 per cent of doctors’ prescriptions in the US are for generic drugs. This widespread acceptance rests on stringent regulation and USFDA (United States Food and Drug Administration) oversight, requiring generic medicines to undergo rigorous bioequivalence testing before they can be approved for use. Despite this global leadership and government initiatives such as the 2008 Jan Aushadhi Scheme, renamed in 2016 as Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), production of pure generic medicines for domestic use has remained a non-starter. The reasons could be:

The Dominance of Branded-Generics: Reputed Pharma companies like Cipla, Lupin, Sun Pharma, Torrent, Dr.Reddy’s, Unichem, Micro Lab,  etc., sell their branded generics rather than produce pure generics. Approximately 70-80% of our market is filled with expensive branded generics.

Quality & Regulations: For a long, bioequivalence testing for all generics was not mandatory in Bharat. This led to fears among people and doctors that cheaper generic drugs might be less effective. Thanks to tightening of regulations under NDCT (New Drugs and Clinical Trials) Rules, 2019, where to market a generic product, especially for export or for competitive domestic distribution, manufacturers must submit robust bioequivalence data to the CDSCO (Central Drugs Standard Control Organisation). This may improve the situation.

Doctor’s Prescriptions: In India, doctors typically prescribe a specific company’s branded drug rather than the generic (API) name, unlike in the US. Medical stores also dispense the same prescription. As prescriptions change to generics, medicines will become cheaper.

Low commissions and lack of awareness: Pure generic drugs have very low profit margins, so medical stores are reluctant to stock and sell them. Furthermore, the public is often unaware that they can exchange expensive brand names for cheaper generics of the same formulation.

Final Word: A quality, effective, economical medication is what a patient wants. If you are unwell with symptoms such as a cold, cough, headache, fever, or dyspepsia, it may not matter much whether you take a generic or a branded medicine or in some cases, no medicine at all because the symptoms often resolve on their own with time. However, for serious conditions such as severe heart failure or multi-vessel coronary artery disease, I would currently advise a branded medicine. This is the choice I would make for myself and for my family.

Several digital pharmacy platforms, or e-pharmacies, have recently emerged, offering cheaper substitutes for branded generic medicines from reputed pharmaceutical companies such as Cipla, Lupin, Sun Pharma, Dr. Morepen, and Ranbaxy. I checked to verify these claims and was surprised by what I found. A strip of 15 Losartan 50 mg tablets for blood pressure, manufactured by Torrent, costs ₹178 at a pharmacy that is about ₹11.80 per tablet. On PlatinumRx, an e-pharmacy, a substitute called Cosart 50 mg, containing the same active ingredient and manufactured by Mumbai-based Cipla, is available at ₹33.20 for a strip of 10 tablets, which is about ₹3.32 per tablet. I am sure there are several other digital pharmacies one can explore.

I conclude with a hope that branded generics become economical due to competition when many more reputed pharmacies start manufacturing cheaper substitutes or generic medicines from small manufacturers become standardised.  As of now, both are on the ‘wish list’. I will end with a reminder to all the Pharma companies that Pharmaceuticals is just not a business, it is a social responsibility.

7 thoughts on “Generic medicines: The dilemma”

  1. My apprehension about generic medicines has been cleared with this read. Very comprehensively explained about the differences and similarities.

  2. A very relevant and well researched article. What matters most is not whether a medicine is branded or generic, but whether it meets strict quality standards. Strong regulation is the real answer.

  3. Good article. But, why the availability of generic medicines in Indian is rare for consumers. I personally experienced several times .

  4. yes we all know that the generic medicines possess tha the API as that of branded one. Doctors , hospitals prescribe branded medicine & the educated mass are afraid to buy the equivalent generic medicines. Here it is high time the govt brings a rule to doctors & hospitals to prescribe only generic medicines for atleast routine BP, Diabetic, fever , headache, cold & allergy. This will greatly help the poor mass

    India being a Hindu Rastra we are forgetting the ayurvedic medicines for all the above problems. Ayur Raksha a govt institution supplies cheap Ayurvedic medicine.

    we are tuned for costly medicines , costly private school, colleges. Further we believe more on Western research & findings which have been told long long back in our Vedic shastra like susruthi samhitha & so on. shambho mahadeva🙏

  5. An excellent detailed informative article. Still most of the people are not that aware the difference between branded and generic medicines, which are costly and cheap. Even some doctors prescribe medicines that are available from their own clinics, which are some times not available outside. We have medication from Ayurveda, Homoeopathy besides Allopathy to treat any kind of health conditions. As rightly pointed out, medicines have become costly.

  6. These type articles which clear the apprehensions among the public about the genuinity of the right n wrong must be given wide publicity. Public is still afraid of purchasing generic medicines because of its very low price. The higher the price the higher the benefit of health. The doctors also r against the generic medicine n do not prescribe for the fear of losing commision. I myself have purchased equal generic medicines number of times. No side effects.
    I recommend this article should be seen in print in other popular print media too n if possible translated into other Indian languages also.

  7. The article on the Generic medicines and the dilemma is well thought out and cleared apprehensions about the generic and branded drugs. I still wonder why the generic medicines which r equivalent in formulations like branded drugs r not very effective. I have seen many doctors who r reluctant to prescribe generic drugs. Hyderabad is the prime pharmaceutical capital and many small scale industries r flourishing and making bulk drugs and smart people buy these drugs and repackage them in attractive packs/wrappers. These r sold at exhorbitant rates under the guise of heavy costs involved in R&D (though they have not spent any moneyon R&D).Government, ICMR and other agencies should come out with specific guidelines abt the price of medicines Their recommendstions should actually reflect the real costs involved when the final product comes into the market.

Leave a Reply

Your email address will not be published. Required fields are marked *